CoChat

Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR: Galantamine is a nicotinic APL

Samochocki, M., Zerlin, M., Jostock, R., Groot Kormelink, P. J., Luyten, W.H. M. L., Albuquerque, E. X., Maelicke, A. · 2000 · Acta Neurologica Scandinavica
Cited by 149

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Galantamine (Reminyl) is a novel drug treatment for mild to moderate Alzheimer's disease (AD). Originally established as a reversible inhibitor of the acetylcholine-degrading enzyme acetylcholinesterase (AChE), galantamine also acts as an allosterically potentiating ligand (APL) on nicotinic acetylcholine receptors (nAChR). Having previously established this second mode of action on nAChRs from murine brain, we demonstrate here the same action of galantamine on the most abundant nAChR in the human brain, the alpha4/beta2 subtype. This nAChR-sensitizing action is not a common property of all, or most, AChE inhibitors, as is shown by the absence of this effect for other therapeutically applied AChE inhibitors including tacrine, metrifonate, rivastigmine and donepezil. The possible benefits for therapy of AD of an APL action on nicotinic receptors is discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1034/j.1600-0404.2000.00310.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 149

Metadata

Authors
Samochocki, M., Zerlin, M., Jostock, R., Groot Kormelink, P. J., Luyten, W. H. M. L., Albuquerque, E. X., & Maelicke, A.
Venue
Acta Neurologica Scandinavica
Publisher
Wiley
Published
2000-12
Volume
102
Pages
68-73
ISSN
0001-6314 (ISSN-L)
OpenAlex
W1955195137
Cited by
149
References
1
FWCI
5.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR: Galantamine is a nicotinic APL. https://app.cochat.ai/papers/10.1034/j.1600-0404.2000.00310.x
The paper
Samochocki, M., Zerlin, M., Jostock, R., Groot Kormelink, P. J., Luyten, W. H. M. L., Albuquerque, E. X., & Maelicke, A. (2000). Galantamine is an allosterically potentiating ligand of the human α4/β2 nAChR: Galantamine is a nicotinic APL. Acta Neurologica Scandinavica. https://doi.org/10.1034/j.1600-0404.2000.00310.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.